Trials / Completed
CompletedNCT04581642
Nociception-Level (NOL) for the Assessment of Pain in Patient Unable to Self-Report
Nociception-Level (NOL) for the Assessment of Pain in Patient Unable to Self-Report: An Exploratory, Prospective, Unblinded, Single-center Study- The MoNOLog Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 33 (actual)
- Sponsor
- Medasense Biometrics Ltd · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In this study we aimed to investigate the performance and effectiveness of NOL and/or NOLedge as a tool for pain assessment in geriatric and critical ill non communicating patients. Our hypothesis was that NOL and the NOLedge may have good correlation with the health-care professional assessment PAINAD, BPS values, even with the use of the drugs affecting autonomic nervous system.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | PMD200 | The NOL technology is comprised of a console and designated finger probe with 4 sensors. The Sensors are Photoplethysmography (PPG) Galvanic Skin Response (GSR), Accelerometer (ACC) and Thermistor (TMP) |
Timeline
- Start date
- 2020-11-01
- Primary completion
- 2021-08-30
- Completion
- 2021-11-30
- First posted
- 2020-10-09
- Last updated
- 2021-12-14
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT04581642. Inclusion in this directory is not an endorsement.